Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
Price and Volume
Detailed Quote| Volume | 1,530,355 |
| Open | 124.54 |
| Bid (Size) | 124.57 (100) |
| Ask (Size) | 127.35 (100) |
| Prev. Close | 124.54 |
| Today's Range | 123.74 - 126.23 |
| 52wk Range | 61.23 - 126.23 |
| Shares Outstanding | 142,334,900 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
0.5% below 52-week high
125.63
61.2352W Low
126.2352W High
1 Week
0.5% below 1-week high
121.621W Low
126.231W High
Halozyme Therapeutics, Inc. - Common Stock (HALO) traded between $61.23 and $126.23 over the past 52 weeks and last traded at $125.63, 0.5% below its 52-week high. Over the past week it ranged between $121.62 and $126.23.
Past 12 Months
1W
+$3.13
1M
+$13.19
3M
+$43.70
6M
+$60.27
YTD
+$55.32
1Y
+$58.74
HALO was +87.8% over the past year, +92.2% over six months, +78.7% year to date, +2.6% in the last week.
12 Months vs Market
HALO
+87.8%
DIA
+11.6%
SPY
+13.1%
QQQ
+15.4%
IWM
+11.9%
Over the past 12 months HALO returned +87.8% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
0.66× 3-mo avg
Today 1,530,355
3-mo avg 2.3M
1W
2.5M
1M
2.4M
3M
2.3M
6M
2.1M
YTD
2.0M
1Y
2.0M
HALO most recently traded 1,530,355 shares against a 3-month average daily volume of 2.3M.
More News
Read More
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
September 24, 2026
1 Cash-Producing Stock to Target This Week and 2 We Question
September 22, 2026
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid
August 31, 2026
3 Market-Beating Stocks for Long-Term Investors
August 28, 2026
1 Healthcare Stock with Exciting Potential and 2 We Avoid
August 27, 2026
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges
August 24, 2026
Halozyme (HALO) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
1 Profitable Stock to Research Further and 2 We Ignore
August 07, 2026
Halozyme Therapeutics Q2 Earnings Call Highlights ↗
August 06, 2026
What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings
August 04, 2026
3 Growth Stocks Set to Flourish
August 03, 2026
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
July 24, 2026
Frequently Asked Questions
Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 125.63
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 10/23/26 04:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 17.88B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 18B shares outstanding.